UNSPSC 51102852: Gramicidin/neomycin/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP219. This VA Drug Class (OP219) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL OPHTHALMIC, OTHER.

UNSPSC 51102852 Gramicidin/neomycin/polymyxin B is a Commodity code that in practice captures state and local procurement of topical antibiotic pharmaceuticals and broader medical supplies, though recent solicitations tagged under this code show substantial scope drift toward naloxone products, emergency medical supplies, and pharmacy benefit programs that bear only marginal relationship to the narrow antibiotic formulation the code nominally describes. State and local issuing bodies soliciting under this code include county health departments, municipal fire rescue divisions, state pharmacy benefit administrators, and multistate cooperative purchasing alliances. The Tampa Fire Department Rescue Division, for example, recently sought 169 line items of medical and emergency response supplies through the City of Tampa's purchasing department, while Seminole County, Florida pursued annual procurement of naloxone and drug deactivation systems. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, has issued a separate RFP for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, and the Texas Health and Human Services Commission posted an RFI regarding direct-to-manufacturer prescription programs.

Geographic activity centers on Florida, Minnesota, Texas, and Oregon, with representation across multiple state and county health systems. The most recent representative opportunities include Seminole County's IFB 60459723LAS (due July 26, 2023, later corrected in the posting to reflect June 30, 2026 release) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's Bid 26-P-00145 (due March 13, 2026) for medical and first aid supplies to the Tampa Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered-market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; MMCAP's RFP S1070000015802 (due March 26, 2026) for generic pharmaceuticals and OTC products through authorized wholesalers with contract effectiveness July 1, 2026; and the Texas HHS Commission's RFI HHS0017013 (response due April 3, 2026) exploring vendor capabilities for direct-to-manufacturer prescription fulfillment. The code shows active state and local procurement activity, though the mismatch between the nominal antibiotic scope and the diverse pharmaceutical, emergency medical supply, and pharmacy-benefit-management work actually being solicited suggests this code is capturing a broader family of medical product procurement than its name indicates.